AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea
· Delayed Price · Currency is KRW 64,300
+1,100 (1.74%)
At close: Apr 28, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 1.50 trillion as of April 28, 2026. Its market cap has increased by 411.10% in one year.
Market Cap
1.50T
Enterprise Value
1.41T
Revenue
2.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
64,300.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 1.50T, an increase of 553.30%. That is a compound annual growth rate of 64.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1,500.93B | 17.80% |
| Dec 30, 2025 | 1,274.14B | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ROKIT Healthcare | 1,400.75B |
| JS Link | 1,517.93B |
| Qurient | 1,592.49B |
| Curocell | 961.00B |
| Inventage Lab | 828.50B |
| Rznomics | 2,580.55B |
| IMBiologics | 792.00B |
| Aimed Bio | 3,246.49B |